Ergoteles’s LifeVantage LFVN Stock Holding History

Ergoteles’s Portfolio LFVN Stock Details LFVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-61,450	Closed	-$416K	–	1438
2021 Q3	$416K	Sell	61,450 -550	-0.9%	-$4.04K	0.02%	664
2021 Q2	$456K	Buy	+62,000	New	+$506K	0.01%	856

Other funds holding LFVN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ergoteles's LFVN Position: Q4 2021 in Review

Ergoteles sold out of LifeVantage (LFVN) in Q4 2021, closing a stake of 61,450 shares — an estimated $416K sold.

Ergoteles first reported a position in LFVN in Q2 2021 and held it in 2 quarters. The position peaked at $456K in Q2 2021. 51 funds tracked by Wall St. Rank hold LFVN as of Q4 2021.

Ergoteles reported no remaining LifeVantage position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 61,450 LifeVantage shares in Q4 2021, an estimated $416K.
Ergoteles first reported a position in LifeVantage in Q2 2021 and held it in 2 quarters.
Ergoteles's LifeVantage position peaked at $456K in Q2 2021.
51 funds tracked by Wall St. Rank held LifeVantage as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.